Piper Jaffray Companies Reaffirms Buy Rating for Phibro Animal Health (PAHC)

Piper Jaffray Companies reissued their buy rating on shares of Phibro Animal Health (NASDAQ:PAHC) in a research note published on Friday, November 10th. They currently have a $42.00 price target on the stock.

Several other analysts have also recently issued reports on PAHC. Credit Suisse Group upped their price objective on shares of Phibro Animal Health from $36.00 to $37.00 and gave the company an outperform rating in a research note on Thursday, August 31st. Zacks Investment Research cut shares of Phibro Animal Health from a buy rating to a hold rating in a research note on Wednesday, November 1st. ValuEngine cut shares of Phibro Animal Health from a buy rating to a hold rating in a research note on Thursday, November 9th. Bank of America reaffirmed an underperform rating and set a $33.00 price objective on shares of Phibro Animal Health in a research note on Wednesday, August 23rd. Finally, BidaskClub cut shares of Phibro Animal Health from a strong-buy rating to a buy rating in a research note on Wednesday, August 23rd. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the stock. The stock presently has an average rating of Hold and a consensus price target of $38.25.

Phibro Animal Health (NASDAQ:PAHC) traded down $0.25 during mid-day trading on Friday, hitting $34.75. 93,600 shares of the stock were exchanged, compared to its average volume of 115,627. The stock has a market capitalization of $1,410.00, a PE ratio of 22.65, a P/E/G ratio of 4.06 and a beta of 1.35. The company has a quick ratio of 1.85, a current ratio of 3.26 and a debt-to-equity ratio of 1.91. Phibro Animal Health has a twelve month low of $26.10 and a twelve month high of $40.25.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Monday, November 6th. The company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.01. The business had revenue of $193.40 million during the quarter, compared to analysts’ expectations of $189.89 million. Phibro Animal Health had a net margin of 8.87% and a return on equity of 42.75%. The company’s quarterly revenue was up 2.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.36 earnings per share. equities research analysts expect that Phibro Animal Health will post 1.57 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Wednesday, December 6th will be issued a $0.10 dividend. The ex-dividend date of this dividend is Tuesday, December 5th. This represents a $0.40 annualized dividend and a dividend yield of 1.15%. Phibro Animal Health’s dividend payout ratio is currently 23.53%.

In other Phibro Animal Health news, CFO Richard G. Johnson sold 29,807 shares of the stock in a transaction that occurred on Thursday, September 7th. The shares were sold at an average price of $35.66, for a total transaction of $1,062,917.62. Following the sale, the chief financial officer now directly owns 4,240 shares in the company, valued at approximately $151,198.40. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, COO Larry Lee Miller sold 32,459 shares of the stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average price of $35.59, for a total transaction of $1,155,215.81. Following the sale, the chief operating officer now owns 4,237 shares in the company, valued at $150,794.83. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 279,791 shares of company stock worth $10,118,331. Company insiders own 51.88% of the company’s stock.

Large investors have recently made changes to their positions in the business. State of Alaska Department of Revenue increased its position in shares of Phibro Animal Health by 80.9% in the 2nd quarter. State of Alaska Department of Revenue now owns 3,690 shares of the company’s stock valued at $136,000 after purchasing an additional 1,650 shares during the last quarter. Municipal Employees Retirement System of Michigan increased its position in shares of Phibro Animal Health by 3.6% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after purchasing an additional 150 shares during the last quarter. KBC Group NV purchased a new stake in shares of Phibro Animal Health in the 2nd quarter valued at approximately $166,000. Victory Capital Management Inc. increased its position in shares of Phibro Animal Health by 17.6% in the 2nd quarter. Victory Capital Management Inc. now owns 5,380 shares of the company’s stock valued at $199,000 after purchasing an additional 807 shares during the last quarter. Finally, Capital Fund Management S.A. purchased a new stake in shares of Phibro Animal Health in the 2nd quarter valued at approximately $210,000. 48.42% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This piece of content was posted by BBNS and is the sole property of of BBNS. If you are viewing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark law. The original version of this piece of content can be viewed at https://baseballnewssource.com/markets/phibro-animal-health-corporation-pahc-earns-buy-rating-from-piper-jaffray-companies/1774574.html.

About Phibro Animal Health

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with our FREE daily email newsletter.

 


Latest News

Tigers Trade Ian Kinsler to Angels for Pair of Minor Leaguers
Tigers Trade Ian Kinsler to Angels for Pair of Minor Leaguers
Manny Machado Could Change Positions or Uniforms
Manny Machado Could Change Positions or Uniforms
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot


Leave a Reply

 
© 2006-2017 BBNS.